-
Arps V, Sudowe S, Kolsch E, 1998: Antigen dose-dependent differences in IgE antibody production are not due to polarization towards Th1 and Th2 cell subsets[J]. Eur J Immunol, 28, 681-686. doi: 10.1002/(ISSN)1521-4141
-
Bauer T, Jilg W, 2006: Hepatitis B surface antigen-specific T and B cell memory in individuals who had lost protective antibodies after hepatitis B vaccination[J]. Vaccine, 24, 572-577. doi: 10.1016/j.vaccine.2005.08.058
-
Bergmann-Leitner ES, Leitner WW, 2014: Adjuvants in the driver's seat: how magnitude, type, fine specificity and longevity of immune responses are driven by distinct classes of immune potentiators[J]. Vaccines (Basel), 2, 252-296. doi: 10.3390/vaccines2020252
-
Binley JM, Klasse PJ, Cao Y, Jones I, Markowitz M, Ho DD, Moore JP, 1997: Differential regulation of the antibody responses to Gag and Env proteins of human immunodeficiency virus type 1[J]. J Virol, 71, 2799-2809.
-
Brunskole Hummel I, Zitzmann A, Erl M, Wenzel JJ, Jilg W, 2016: Characteristics of immune memory 10-15 years after primary hepatitis B vaccination[J]. Vaccine, 34, 636-642. doi: 10.1016/j.vaccine.2015.12.033
-
Calabro S, Tritto E, Pezzotti A, Taccone M, Muzzi A, Bertholet S, De GE, O'Hagan DT, Baudner B, Seubert A, 2013: The adjuvant effect of MF59 is due to the oil-in-water emulsion formulation, none of the individual components induce a comparable adjuvant effect[J]. Vaccine, 31, 3363-3369. doi: 10.1016/j.vaccine.2013.05.007
-
Carrasco YR, Batista FD, 2007: B cells acquire particulate antigen in a macrophage-rich area at the boundary between the follicle and the subcapsular sinus of the lymph node[J]. Immunity, 27, 160-171. doi: 10.1016/j.immuni.2007.06.007
-
Carter LL, Carreno BM, 2003: Cytotoxic T-lymphocyte antigen-4 and programmed death-1 function as negative regulators of lymphocyte activation[J]. Immunol Res, 28, 49-59. doi: 10.1385/IR:28:1
-
Ciabattini A, Pettini E, Fiorino F, Pastore G, Andersen P, Pozzi G, Medaglini D, 2016: Modulation of primary immune response by different vaccine adjuvants[J]. Front Immunol, 7, 427-.
-
Civin CI, Levine HB, Williamson AR, Schlossman SF, 1976: The effects of antigen dose and adjuvant on the antibody response; amplification of restricted B cell clones[J]. J Immunol, 116, 1400-1406.
-
Cubas RA, Mudd JC, Savoye AL, Perreau M, van Grevenynghe J, Metcalf T, Connick E, Meditz A, Freeman GJ, Abesada-Terk G Jr, Jacobson JM, Brooks AD, Crotty S, Estes JD, Pantaleo G, Lederman MM, Haddad EK, 2013: Inadequate T follicular cell help impairs B cell immunity during HIV infection[J]. Nat Med, 19, 494-499. doi: 10.1038/nm.3109
-
Eivazi S, Bagheri S, Hashemzadeh MS, Ghalavand M, Qamsari ES, Dorostkar R, Yasemi M, 2016: Development of T follicular helper cells and their role in disease and immune system[J]. Biomed Pharmacother, 84, 1668-1678. doi: 10.1016/j.biopha.2016.10.083
-
Evans TG, Frey S, Israel H, Chiu J, El-Habib R, Gilbert P, Gaitan A, Montefiori DC, Network HIVVT, 2004: Long-term memory B-cell responses in recipients of candidate human immunodeficiency virus type 1 vaccines[J]. Vaccine, 22, 2626-2630. doi: 10.1016/j.vaccine.2003.12.011
-
Fang JH, Hora M, 2000: The adjuvant MF59: a 10-year perspective Gary Ott[J]. Ramachandran Radhakrishnan., 42, 211-228.
-
Fouda, Yates, Pollara, Shen, Overman, Mahlokozera, Wilks, Kang, Salazar-Gonzalez, Salazar, Kalilani, Meshnick, Hahn, Shaw, Lovingood, Denny, Haynes, Letvin, Ferrari, Montefiori, Tomaras, Permar, Center for HIVAVI, 2011: HIV-specific functional antibody responses in breast milk mirror those in plasma and are primarily mediated by IgG antibodies[J]. J Virol, 85, 9555-9567. doi: 10.1128/JVI.05174-11
-
Gitlin AD, Shulman Z, Nussenzweig MC, 2014: Clonal selection in the germinal centre by regulated proliferation and hypermutation[J]. Nature, 509, 637-640. doi: 10.1038/nature13300
-
Good-Jacobson KL, Szumilas CG, Chen L, Sharpe AH, Tomayko MM, Shlomchik MJ, 2010: PD-1 regulates germinal center B cell survival and the formation and affinity of long-lived plasma cells[J]. Nat Immunol, 11, 535-542. doi: 10.1038/ni.1877
-
Hauck NC, Kirpach J, Kiefer C, Farinelle S, Maucourant S, Morris SA, Rosenberg W, He FQ, Muller CP, Lu IN, 2018: Applying unique molecular identifiers in next generation sequencing reveals a constrained viral quasispecies evolution under cross-reactive antibody pressure targeting long alpha helix of hemagglutinin[J]. Viruses, 10, 148-. doi: 10.3390/v10040148
-
He B, Qiao X, Klasse PJ, Chiu A, Chadburn A, Knowles DM, Moore JP, Cerutti A, 2006: HIV-1 envelope triggers polyclonal Ig class switch recombination through a CD40-independent mechanism involving BAFF and C-type lectin receptors[J]. J Immunol, 176, 3931-3941. doi: 10.4049/jimmunol.176.7.3931
-
Hollister K, Chen Y, Wang S, Wu H, Mondal A, Clegg N, Lu S, Dent A, 2014: The role of follicular helper T cells and the germinal center in HIV-1 gp120 DNA prime and gp120 protein boost vaccination[J]. Hum Vaccin Immunother, 10, 1985-1992. doi: 10.4161/hv.28659
-
Jardine J, Julien JP, Menis S, Ota T, Kalyuzhniy O, McGuire A, Sok D, Huang PS, MacPherson S, Jones M, Nieusma T, Mathison J, Baker D, Ward AB, Burton DR, Stamatatos L, Nemazee D, Wilson IA, Schief WR, 2013: Rational HIV immunogen design to target specific germline B cell receptors[J]. Science, 340, 711-716. doi: 10.1126/science.1234150
-
Jogdand GM, Mohanty S, Devadas S, 2016: Regulators of Tfh cell differentiation[J]. Front Immunol, 7, 520-.
-
Junt T, Moseman EA, Iannacone M, Massberg S, Lang PA, Boes M, Fink K, Henrickson SE, Shayakhmetov DM, Di Paolo NC, van Rooijen N, Mempel TR, Whelan SP, von Andrian UH, 2007: Subcapsular sinus macrophages in lymph nodes clear lymph-borne viruses and present them to antiviral B cells[J]. Nature, 450, 110-114. doi: 10.1038/nature06287
-
Klasse PJ, LaBranche CC, Ketas TJ, Ozorowski G, Cupo A, Pugach P, Ringe RP, Golabek M, van Gils MJ, Guttman M, Lee KK, Wilson IA, Butera ST, Ward AB, Montefiori DC, Sanders RW, Moore JP, 2016: Sequential and simultaneous immunization of rabbits with HIV-1 envelope glycoprotein SOSIP.664 trimers from clades A, B and C[J]. PLoS Pathog, , e1005864-.
-
Kurosaki T, Kometani K, Ise W, 2015: Memory B cells[J]. Nat Rev Immunol, 15, 149-159. doi: 10.1038/nri3802
-
Lanzavecchia A, 1985: Antigen-specific interaction between T and B cells[J]. Nature, 314, 537-539. doi: 10.1038/314537a0
-
Liao HX, Lynch R, Zhou T, Gao F, Alam SM, Boyd SD, Fire AZ, Roskin KM, Schramm CA, Zhang Z, Zhu J, Shapiro L, Program NCS, Mullikin JC, Gnanakaran S, Hraber P, Wiehe K, Kelsoe G, Yang G, Xia SM, Montefiori DC, Parks R, Lloyd KE, Scearce RM, Soderberg KA, Cohen M, Kamanga G, Louder MK, Tran LM, Chen Y, Cai F, Chen S, Moquin S, Du X, Joyce MG, Srivatsan S, Zhang B, Zheng A, Shaw GM, Hahn BH, Kepler TB, Korber BT, Kwong PD, Mascola JR, Haynes BF, 2013: Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus[J]. Nature, 496, 469-476. doi: 10.1038/nature12053
-
Moody MA, Yates NL, Amos JD, Drinker MS, Eudailey JA, Gurley TC, Marshall DJ, Whitesides JF, Chen X, Foulger A, Yu JS, Zhang R, Meyerhoff RR, Parks R, Scull JC, Wang L, Vandergrift NA, Pickeral J, Pollara J, Kelsoe G, Alam SM, Ferrari G, Montefiori DC, Voss G, Liao HX, Tomaras GD, Haynes BF, 2012: HIV-1 gp120 vaccine induces affinity maturation in both new and persistent antibody clonal lineages[J]. J Virol, 86, 7496-7507. doi: 10.1128/JVI.00426-12
-
Nabi G, Temchura V, Grossmann C, Kuate S, Tenbusch M, Uberla K, 2012: T cell independent secondary antibody responses to the envelope protein of simian immunodeficiency virus[J]. Retrovirology, 9, 42-. doi: 10.1186/1742-4690-9-42
-
Phan TG, Grigorova I, Okada T, Cyster JG, 2007: Subcapsular encounter and complement-dependent transport of immune complexes by lymph node B cells[J]. Nat Immunol, 8, 992-1000. doi: 10.1038/ni1494
-
Pillai S, 2013: Love the one you're with: the HIV, B cell and TFH cell triangle[J]. Nat Med, 19, 401-402. doi: 10.1038/nm.3141
-
Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, Chiu J, Paris R, Premsri N, Namwat C, de Souza M, Adams E, Benenson M, Gurunathan S, Tartaglia J, McNeil JG, Francis DP, Stablein D, Birx DL, Chunsuttiwat S, Khamboonruang C, Thongcharoen P, Robb ML, Michael NL, Kunasol P, Kim JH, Investigators M-T, 2009: Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand[J]. N Engl J Med, 361, 2209-2220. doi: 10.1056/NEJMoa0908492
-
Robb ML, Rerks-Ngarm S, Nitayaphan S, Pitisuttithum P, Kaewkungwal J, Kunasol P, Khamboonruang C, Thongcharoen P, Morgan P, Benenson M, Paris RM, Chiu J, Adams E, Francis D, Gurunathan S, Tartaglia J, Gilbert P, Stablein D, Michael NL, Kim JH, 2012: Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: a post hoc analysis of the Thai phase 3 efficacy trial RV 144[J]. Lancet Infect Dis, 12, 531-537. doi: 10.1016/S1473-3099(12)70088-9
-
Romano L, Paladini S, Galli C, Raimondo G, Pollicino T, Zanetti AR, 2015: Hepatitis B vaccination[J]. Hum Vaccin Immunother, 11, 53-57. doi: 10.4161/hv.34306
-
Roozendaal R, Mempel TR, Pitcher LA, Gonzalez SF, Verschoor A, Mebius RE, von Andrian UH, Carroll MC, 2009: Conduits mediate transport of low-molecular-weight antigen to lymph node follicles[J]. Immunity, 30, 264-276. doi: 10.1016/j.immuni.2008.12.014
-
Rouers A, Klingler J, Su B, Samri A, Laumond G, Even S, Avettand-Fenoel V, Richetta C, Paul N, Boufassa F, Hocqueloux L, Mouquet H, Rouzioux C, Lambotte O, Autran B, Graff-Dubois S, Moog C, Moris A, Cohort AC, 2017: HIV-specific B cell frequency correlates with neutralization breadth in patients naturally controlling HIV-infection[J]. EBioMedicine, 21, 158-169. doi: 10.1016/j.ebiom.2017.05.029
-
Rweyemamu MM, Black L, Boge A, Thorne AC, Terry GM, 1984: The relationship between the 140S antigen dose in aqueous foot-and-mouth disease vaccines and the serum antibody response of cattle[J]. J Biol Stand, 12, 111-120. doi: 10.1016/S0092-1157(84)80027-X
-
Sallusto F, Lanzavecchia A, Araki K, Ahmed R, 2010: From vaccines to memory and back[J]. Immunity, 33, 451-463. doi: 10.1016/j.immuni.2010.10.008
-
Sanders RW, van Gils MJ, Derking R, Sok D, Ketas TJ, Burger JA, Ozorowski G, Cupo A, Simonich C, Goo L, Arendt H, Kim HJ, Lee JH, Pugach P, Williams M, Debnath G, Moldt B, van Breemen MJ, Isik G, Medina-Ramirez M, Back JW, Koff WC, Julien JP, Rakasz EG, Seaman MS, Guttman M, Lee KK, Klasse PJ, LaBranche C, Schief WR, Wilson IA, Overbaugh J, Burton DR, Ward AB, Montefiori DC, Dean H, Moore JP, 2015: HIV-1 VACCINES HIV-1 neutralizing antibodies induced by native-like envelope trimers[J]. Science, 349, aac4223-. doi: 10.1126/science.aac4223
-
Sather DN, Armann J, Ching LK, Mavrantoni A, Sellhorn G, Caldwell Z, Yu X, Wood B, Self S, Kalams S, Stamatatos L, 2009: Factors associated with the development of cross-reactive neutralizing antibodies during human immunodeficiency virus type 1 infection[J]. J Virol, 83, 757-769. doi: 10.1128/JVI.02036-08
-
Sliepen K, Sanders RW, 2016: HIV-1 envelope glycoprotein immunogens to induce broadly neutralizing antibodies[J]. Expert Rev Vaccines, 15, 349-365.
-
Souza CK, Rajao DS, Sandbulte MR, Lopes S, Lewis NS, Loving CL, Gauger PC, Vincent AL, 2018: The type of adjuvant in whole inactivated influenza a virus vaccines impacts vaccine-associated enhanced respiratory disease[J]. Vaccine, 36, 6103-6110. doi: 10.1016/j.vaccine.2018.08.072
-
Spillane KM, Tolar P, 2017: B cell antigen extraction is regulated by physical properties of antigen-presenting cells[J]. J Cell Biol, 216, 217-230. doi: 10.1083/jcb.201607064
-
Velu V, Titanji K, Zhu B, Husain S, Pladevega A, Lai L, Vanderford TH, Chennareddi L, Silvestri G, Freeman GJ, Ahmed R, Amara RR, 2009: Enhancing SIV-specific immunity in vivo by PD-1 blockade[J]. Nature, 458, 206-210. doi: 10.1038/nature07662
-
Wagatsuma T, Kuno A, Angata K, Tajiri K, Takahashi J, Korenaga M, Mizokami M, Narimatsu H, 2018: Highly sensitive glycan profiling of hepatitis B viral particles and a simple method for dane particle enrichment[J]. Anal Chem, 90, 10196-10203. doi: 10.1021/acs.analchem.8b01030
-
Wang JY, Song WT, Li Y, Chen WJ, Yang D, Zhong GC, Zhou HZ, Ren CY, Yu HT, Ling H, 2011: Improved expression of secretory and trimeric proteins in mammalian cells via the introduction of a new trimer motif and a mutant of the tPA signal sequence[J]. Appl Microbiol Biotechnol, 91, 731-740. doi: 10.1007/s00253-011-3297-0
-
Wang B, Cai CL, Li B, Zhang W, Zhu Y, Chen WH, Zhuo F, Shi ZL, Yang XL, 2017: Detection and characterization of three zoonotic viruses in wild rodents and shrews from Shenzhen city, China[J]. Virol Sin, 32, 290-297. doi: 10.1007/s12250-017-3973-z
-
West DJ, Calandra GB, 1996: Vaccine induced immunologic memory for hepatitis B surface antigen: implications for policy on booster vaccination[J]. Vaccine, 14, 1019-1027. doi: 10.1016/0264-410X(96)00062-X
-
Wolfert MA, Boons GJ, 2013: Adaptive immune activation: glycosylation does matter[J]. Nat Chem Biol, 9, 776-784. doi: 10.1038/nchembio.1403
-
Yu HT, Wang JY, Tian D, Wang MX, Li Y, Yuan L, Chen WJ, Li D, Zhuang M, Ling H, 2016: Comparison of the patterns of antibody recall responses to HIV-1 gp120 and hepatitis B surface antigen in immunized mice[J]. Vaccine, 34, 6276-6284. doi: 10.1016/j.vaccine.2016.10.063
-
Zeng M, Hu Z, Shi X, Li X, Zhan X, Li XD, Wang J, Choi JH, Wang KW, Purrington T, Tang M, Fina M, DeBerardinis RJ, Moresco EM, Pedersen G, McInerney GM, Karlsson Hedestam GB, Chen ZJ, Beutler B, 2014: MAVS, cGAS, and endogenous retroviruses in T-independent B cell responses[J]. Science, 346, 1486-1492. doi: 10.1126/science.346.6216.1486
-
Zhao Q, Li S, Yu H, Xia N, Modis Y, 2013: Virus-like particle-based human vaccines: quality assessment based on structural and functional properties[J]. Trends Biotechnol, 31, 654-663. doi: 10.1016/j.tibtech.2013.09.002
-
Zwart G, van der Hoek L, Valk M, Cornelissen MT, Baan E, Dekker J, Koot M, Kuiken CL, Goudsmit J, 1994: Antibody responses to HIV-1 envelope and gag epitopes in HIV-1 seroconverters with rapid versus slow disease progression[J]. Virology, 201, 285-293. doi: 10.1006/viro.1994.1293